Procarbazine (Matulane)
895
relevant articles (73 outcomes,
141 trials/studies)
found for this Drug
Description:
An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
Also Known As:
Matulane; Procarbazine Hydrochloride; Cambridge Laboratories Brand of Procarbazine Hydrochloride; Natulan; Procarbazine Monohydrobromide; Procarbazine Monohydrochloride; Roche Brand of Procarbazine Hydrochloride; Sigma-Tau Brand of Procarbazine; Sigma-Tau Brand of Procarbazine Hydrochloride; Hydrochloride, Procarbazine; Monohydrobromide, Procarbazine; Monohydrochloride, Procarbazine; Procarbazine Sigma-Tau Brand; Sigma Tau Brand of Procarbazine; Sigma Tau Brand of Procarbazine Hydrochloride; Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)-
Relationship Network
Drug Context: Research Results